Skip to main content

Ardelyx, Inc.

ARDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001437402

In the last 90 days, Ardelyx, Inc. insiders filed 0 open-market purchases and 9 sales; 250 institutions reported holding it in 13F filings for Q2 2026, worth $906.4M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Ardelyx, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
9 filings
8 insiders, $697.1K in total
Insiders trading
8
Net value
−$697.1K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Ardelyx, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Ardelyx, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Hohenleitner SusanChief Financial Officer227,520Aug 25, 20264
Reilly Joseph JamesSee Remarks145,854Aug 25, 20265
Bishop John ESee Remarks317,095Aug 25, 20264
Brady James ParkerChief Human Resources Officer245,930Aug 25, 20264
Foster Eric DuaneChief Commercial Officer409,410Aug 25, 20265
Kelliher MikeChief Business Officer349,660Aug 25, 20265
Williams Laura AChief Patient Officer367,456Aug 25, 20267
Raab MichaelPresident & CEO1,619,792Aug 25, 202611
Mott David MDirector3,349,655Jun 18, 20262
Bertrand William C JRDirector329,507Jun 18, 20261
Rodgers Richard JDirector439,998Jun 18, 20261
Bazemore Robert BDirector68,006Jun 18, 20261
Parsey MerdadDirector83,746Jun 18, 20261
Cadoret-Manier OnaizaDirector178,156Jun 18, 20261
Bhanji MunaDirector163,808Jun 18, 20261
Grammer Elizabeth ASee Remarks299,895Nov 25, 20251
Renz Justin AChief Financial Officer409,052Aug 25, 20250
Rosenbaum David P.Chief Development Officer151,373IndirectNov 22, 20240
Blanks RobertSee Remarks314,421Nov 22, 20240
Felsch Robert OraSee Remarks91,560Aug 22, 20240
Rodriguez SusanChief Commercial Officer449,092May 23, 20240
Lundberg Jan MDirector146,794Jun 16, 20230
Block Geoffrey A.Director–Jun 16, 20230
Sandell Scott D10% Owner2,258,850IndirectDec 27, 20210
Baskett Forest10% Owner2,258,850IndirectDec 27, 20210
Jacobs Jeffrey WChief Scientific Officer119,483Nov 24, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 24, 2022 (view filing)Aug 222 daysRodriguez SusanChief Commercial OfficerSSale−3.42K$0.98−$3.35K−1.2%286.2K after2 lots
Aug 29, 2022 (view filing)Aug 263 daysBlanks RobertSee RemarksSSale−21.8K$1.04−$22.7K−6.9%295.8K after
Sep 1, 2022 (view filing)Aug 311 dayGrammer Elizabeth ASee RemarksPPurchase+3.00K$0.62+$1.86K+1.2%256.1K after
Sep 1, 2022 (view filing)Aug 311 dayRaab MichaelPresident & CEOPPurchase+3.00K$0.62+$1.86K+0.5%665.7K after
Sep 1, 2022 (view filing)Aug 311 dayWilliams Laura AChief Medical OfficerPPurchase+3.00K$0.62+$1.86K+1.2%245.4K after
Sep 1, 2022 (view filing)Aug 311 dayRenz Justin AChief Financial OfficerPPurchase+3.00K$0.62+$1.86K+1.2%263.5K after
Sep 1, 2022 (view filing)Aug 311 dayRosenbaum David P.Chief Development OfficerPPurchase+3.00K$0.62+$1.86K+3.4%92.4K after
Sep 1, 2022 (view filing)Sep 1Same dayRosenbaum David P.Chief Development OfficerSSale−3.00K$0.92−$2.76K−3.2%89.4K after
Sep 1, 2022 (view filing)Aug 311 dayFelsch Robert OraSee RemarksPPurchase+3.00K$0.62+$1.86K+3.4%91.4K after
Oct 7, 2022 (view filing)Oct 52 daysBlanks RobertSee RemarksSSale−100.0K$1.50−$150.0K−33.8%195.8K after
Nov 17, 2022 (view filing)Nov 17Same dayMott David MDirectorPPurchase+567.0K$1.76+$997.9K+94.5%1.17M after
Nov 23, 2022 (view filing)Nov 221 dayBlanks RobertSee RemarksSSale−1.46K$1.95−$2.85K−0.7%194.4K after3 lots
Nov 23, 2022 (view filing)Nov 221 dayWilliams Laura AChief Medical OfficerSSale−1.24K$1.95−$2.42K−0.5%244.2K after3 lots
Nov 23, 2022 (view filing)Nov 221 dayRenz Justin AChief Financial OfficerSSale−1.50K$1.95−$2.93K−0.6%262.0K after2 lots
Nov 23, 2022 (view filing)Nov 221 dayRaab MichaelPresident & CEOSSale−6.22K$1.95−$12.1K−0.9%659.5K after3 lots
Nov 23, 2022 (view filing)Nov 221 dayRodriguez SusanChief Commercial OfficerSSale−3.46K$1.95−$6.74K−1.2%282.7K after3 lots
Nov 23, 2022 (view filing)Nov 221 dayGrammer Elizabeth ASee RemarksSSale−1.24K$1.95−$2.42K−0.5%254.9K after3 lots
Nov 23, 2022 (view filing)Nov 221 dayRosenbaum David P.Chief Development OfficerSSale−1.46K$1.95−$2.85K−0.5%301.0K after3 lots
Nov 23, 2022 (view filing)Nov 221 dayRosenbaum David P.Chief Development OfficerSSale−484$1.95−$943.69−0.5%88.9K after3 lots
Feb 24, 2023 (view filing)Feb 213 daysLateRosenbaum David P.Chief Development OfficerSSale−3.39K$3.00−$10.2K−0.9%375.6K after
Feb 24, 2023 (view filing)Feb 213 daysLateRosenbaum David P.Chief Development OfficerSSale−1.11K$3.00−$3.34K−1.0%113.1K after
Feb 24, 2023 (view filing)Feb 213 daysLateRenz Justin AChief Financial OfficerSSale−3.44K$3.00−$10.3K−1.0%336.6K after
Feb 24, 2023 (view filing)Feb 213 daysLateFelsch Robert OraSee RemarksSSale−3.21K$3.00−$9.64K−2.7%114.2K after
Feb 24, 2023 (view filing)Feb 213 daysLateRaab MichaelPresident & CEOSSale−13.4K$3.00−$40.3K−1.5%896.0K after
Feb 24, 2023 (view filing)Feb 213 daysLateGrammer Elizabeth ASee RemarksSSale−2.91K$3.00−$8.74K−0.9%330.0K after
Feb 24, 2023 (view filing)Feb 213 daysLateBlanks RobertSee RemarksSSale−3.39K$3.00−$10.2K−1.2%269.0K after
Feb 24, 2023 (view filing)Feb 213 daysLateWilliams Laura AChief Medical OfficerSSale−3.19K$3.00−$9.56K−1.0%319.0K after
Mar 2, 2023 (view filing)Feb 219 daysLateRodriguez SusanChief Commercial OfficerSSale−5.59K$3.00−$16.8K−1.5%355.1K after
Mar 31, 2023 (view filing)Mar 292 daysRosenbaum David P.Chief Development OfficerSSale−3.00K$4.63−$13.9K−2.6%113.1K after
May 25, 2023 (view filing)May 232 daysWilliams Laura AChief Medical OfficerSSale−2.58K$3.65−$9.43K−0.8%319.4K after
May 25, 2023 (view filing)May 232 daysRosenbaum David P.Chief Development OfficerSSale−2.83K$3.65−$10.3K−0.8%372.8K after
May 25, 2023 (view filing)May 232 daysRosenbaum David P.Chief Development OfficerSSale−934$3.65−$3.41K−0.8%112.2K after
May 25, 2023 (view filing)May 232 daysRodriguez SusanChief Commercial OfficerSSale−4.71K$3.65−$17.2K−1.3%353.4K after
May 25, 2023 (view filing)May 232 daysRenz Justin AChief Financial OfficerSSale−2.87K$3.65−$10.5K−0.8%336.7K after
May 25, 2023 (view filing)May 232 daysBlanks RobertSee RemarksSSale−2.83K$3.65−$10.3K−1.1%266.1K after
May 25, 2023 (view filing)May 232 daysGrammer Elizabeth ASee RemarksSSale−2.38K$3.65−$8.70K−0.7%330.5K after
May 25, 2023 (view filing)May 232 daysRaab MichaelPresident & CEOSSale−11.4K$3.65−$41.5K−1.3%887.7K after
May 25, 2023 (view filing)May 232 daysFelsch Robert OraSee RemarksSSale−1.05K$3.65−$3.82K−0.9%116.2K after
Jun 27, 2023 (view filing)Jun 234 daysBlanks RobertSee RemarksSSale−33.3K$3.63−$121.0K−11.1%266.1K after10b5-1
Jun 29, 2023 (view filing)Jun 272 daysWilliams Laura AChief Medical OfficerSSale−25.0K$3.35−$83.8K−7.8%294.4K after
Aug 23, 2023 (view filing)Aug 212 daysBlanks RobertSee RemarksSSale−2.85K$3.55−$10.1K−1.1%263.3K after
Aug 23, 2023 (view filing)Aug 212 daysFelsch Robert OraSee RemarksSSale−1.05K$3.55−$3.72K−0.9%115.1K after
Aug 23, 2023 (view filing)Aug 212 daysGrammer Elizabeth ASee RemarksSSale−2.39K$3.55−$8.49K−0.7%328.1K after
Aug 23, 2023 (view filing)Aug 212 daysRaab MichaelPresident & CEOSSale−11.4K$3.55−$40.5K−1.3%876.2K after
Aug 23, 2023 (view filing)Aug 212 daysRenz Justin AChief Financial OfficerSSale−2.88K$3.55−$10.2K−0.9%333.8K after
Aug 23, 2023 (view filing)Aug 212 daysRosenbaum David P.Chief Development OfficerSSale−2.85K$3.55−$10.1K−0.8%369.9K after
Aug 23, 2023 (view filing)Aug 212 daysRosenbaum David P.Chief Development OfficerSSale−937$3.55−$3.33K−0.8%111.2K after
Aug 23, 2023 (view filing)Aug 212 daysWilliams Laura AChief Medical OfficerSSale−2.59K$3.55−$9.20K−0.9%291.8K after
Aug 23, 2023 (view filing)Aug 212 daysRodriguez SusanChief Commercial OfficerSSale−4.73K$3.55−$16.8K−1.3%348.7K after
Sep 12, 2023 (view filing)Sep 84 daysRosenbaum David P.Chief Development OfficerSSale−2.90K$4.55−$13.2K−0.8%367.0K after10b5-1